# Xiaojun Huang

Source: https://onco.cc/people/huang-xiaojun/  
OnCo record `huang-xiaojun` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Xiaojun Huang built the Beijing Protocol for stem cell transplants from half-matched family donors, which means almost every Chinese leukaemia patient can now find a donor.

## Summary

Huang's group developed haploidentical transplantation without in vitro T-cell depletion using G-CSF-primed grafts and anti-thymocyte globulin (Bone Marrow Transplantation 2006), now the most common transplant type in China and increasingly used worldwide; his centre performs more haploidentical transplants than any other. Later work covers relapse prevention, GVHD and CAR-T bridging to transplant. Academician of the Chinese Academy of Engineering.

## Fields

- Kind: Person
- Last checked: 2026-09-10
- Also known as: Huang Xiao-Jun; 黄晓军
- Tags: china
- Role: Director, Peking University Institute of Hematology; Peking University People's Hospital
- Specialisms: Haematopoietic stem cell transplantation; Haploidentical transplantation; Acute leukaemia; Graft-versus-host disease

## Sources

- Peking University People's Hospital: https://www.pkuph.cn/
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Huang%20XJ%5BAuthor%5D%20haploidentical%20Peking%20University

## Connected records

- cancers: [Acute lymphoblastic leukaemia](https://onco.cc/cancers/all-leukemia/), [Acute myeloid leukaemia](https://onco.cc/cancers/aml/)
- technologies: [Allogeneic (off-the-shelf) cell therapy](https://onco.cc/technologies/allogeneic-cell-therapy/)
- institutions: [Peking University People's Hospital](https://onco.cc/institutions/pku-peoples-hospital/)
- terms: [Allogeneic stem cell transplant (allo-SCT)](https://onco.cc/terms/allogeneic-transplant/), [Graft-versus-host disease (GVHD) and graft-versus-leukaemia](https://onco.cc/terms/gvhd/)

---
JSON: https://onco.cc/api/v1/entities/huang-xiaojun.json